|
1
|
Reis-Filho JS, Lakhani SR, Gobbi H and
Sneige N: Metaplastic carcinoma. WHO Classification of Tumours of
the Breast. World Health Organization Classification of Tumours.
Vol 4. 4th edition. International Agency for Research on Cancer,
Lyon, pp48-52, 2012.
|
|
2
|
McMullen ER, Zoumberos NA and Kleer CG:
Metaplastic breast carcinoma: Update on histopathology and
molecular alterations. Arch Pathol Lab Med. 143:1492–1496.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pezzi CM, Patel-Parekh L, Cole K, Franko
J, Klimberg VS and Bland K: Characteristics and treatment of
metaplastic breast cancer: Analysis of 892 cases from the national
cancer data base. Ann Surg Oncol. 14:166–173. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Barnes PJ, Boutilier R, Chiasson D and
Rayson D: Metaplastic breast carcinoma: Clinical-pathological
characteristics and HER2/neu expression. Breast Cancer Res Treat.
91:173–178. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moreno AC, Lin YH, Bedrosian I, Shen Y,
Babiera GV and Shaitelman SF: Outcomes after treatment of
metaplastic versus other breast cancer subtypes. J Cancer.
11:1341–1350. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huvos AG, Lucas JC Jr and Foote FW Jr:
Metaplastic breast carcinoma. Rare form of mammary cancer. NY State
J Med. 73:1078–1082. 1973.PubMed/NCBI
|
|
7
|
McCart Reed AE, Kalaw E, Nones K,
Bettington M, Lim M, Bennett J, Johnstone K, Kutasovic JR, Saunus
JM, Kazakoff S, et al: Phenotypic and molecular dissection of
metaplastic breast cancer and the prognostic implications. J
Pathol. 247:214–227. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bae SY, Lee SK, Koo MY, Hur SM, Choi MY,
Cho DH, Kim S, Choe JH, Lee JE, Kim JH, et al: The prognoses of
metaplastic breast cancer patients compared to those
triple-negative breast cancer patients. Breast Cancer Res Treat.
126:471–478. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Beatty JD, Atwood M, Tickman R and Reiner
M: Metaplastic breast cancer: Clinical significance. Am J Surg.
191:657–664. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jung SY, Kim HY, Nam BH, Min SY, Lee SJ,
Park C, Kwon Y, Kim EA, Ko KL, Shin KH, et al: Worse prognosis of
metaplastic breast cancer patients than other patients with
triple-negative breast cancer. Breast Cancer Res Treat.
120:627–637. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Oberman HA: Metaplastic carcinoma of the
breast. A clinicopathologic study of 29 patients. Am J Surg Pathol.
11:918–929. 1987.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Esbah O, Turkoz FP, Turker I, Durnali A,
Ekinci AS, Bal O, Sonmez OU, Budakoglu B, Arslan UY and Oksuzoglu
B: Metaplastic breast carcinoma: Case series and review of the
literature. Asian Pac J Cancer Prev. 13:4645–4649. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Leyrer CM, Berriochoa CA, Agrawal S,
Donaldson A, Calhoun BC, Shah C, Stewart R, Moore HCF and Tendulkar
RD: Predictive factors on outcomes in metaplastic breast cancer.
Breast Cancer Res Treat. 165:499–504. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gortman AM, Aherne NJ, Amalaseelan J, Last
A, Westhuyzen J, Chamberlain L and Shakespeare TP: Long-term
outcomes of patients with conserved breast cancer treated with
adjuvant hypofractionated prone breast intensity-modulated
radiation therapy. J Med Imaging Radiat Oncol. 64:845–851.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wen S, Manuel L, Doolan M, Westhuyzen J,
Shakespeare TP and Aherne NJ: Effect of clinical and treatment
factors on survival outcomes of triple negative breast cancer
patients. Breast Cancer (Dove Med Press). 12:27–35. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dean J, Hansen CJ, Westhuyzen J, Waller B,
Turnbull K, Wood M and Last A: Tangential intensity modulated
radiation therapy (IMRT) to the intact breast. J Med Radiat Sci.
63:217–223. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Mortimer JW, McLachlan CS, Hansen CJ,
Assareh H, Last A, McKay MJ and Shakespeare TP: Use of
hypofractionated post-mastectomy radiotherapy reduces health costs
by over $2000 per patient: An Australian perspective. J Med Imaging
Radiat Oncol. 60:146–153. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nelson RA, Guye ML, Luu T and Lai LL:
Survival outcomes of metaplastic breast cancer patients: Results
from a US population-based analysis. Ann Surg Oncol. 22:24–31.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee H, Jung SY, Ro JY, Kwon Y, Sohn JH,
Park IH, Lee KS, Lee S, Kim SW, Kang HS, et al: Metaplastic breast
cancer: Clinicopathological features and its prognosis. J Clin
Pathol. 65:441–446. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Song Y, Liu X, Zhang G, Song H, Ren Y, He
X, Wang Y, Zhang J, Zhang Y, Sun S, et al: Unique
clinicopathological features of metaplastic breast carcinoma
compared with invasive ductal carcinoma and poor prognostic
indicators. World J Surg Oncol. 11:129–138. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shah DR, Tseng WH and Martinez SR:
Treatment options for metaplastic breast cancer. ISRN Oncol.
2012(706162)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rayson D, Adjei AA, Suman VJ, Wold LE and
Ingle JN: Metaplastic breast cancer: Prognosis and response to
systemic therapy. Ann Oncol. 10:413–419. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen IC, Lin CH, Huang CS, Lien HC, Hsu C,
Kuo WH, Lu YS and Cheng AL: Lack of efficacy to systemic
chemotherapy for treatment of metaplastic carcinoma of the breast
in the modern era. Breast Cancer Res Treat. 130:345–351.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chao TC, Wang CS, Chen SC and Chen MF:
Metaplastic carcinomas of the breast. J Surg Oncol. 71:220–225.
1999.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Böler DE, Kara H, Sağlıcan Y, Tokat F and
Uras C: Metaplastic carcinoma of the breast: A case series and
review of the literature. J Oncol Sci. 2:38–42. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Brenner RJ, Turner RR, Schiller V, Arndt
RD and Giuliano A: Metaplastic carcinoma of the breast: Report of
three cases. Cancer. 82:1082–1087. 1998.PubMed/NCBI
|
|
27
|
Wang J, Shi M, Ling R, Xia Y, Luo S, Fu X,
Xiao F, Li J, Long X, Wang J, et al: Adjuvant chemotherapy and
radiotherapy in triple-negative breast carcinoma: A prospective
randomized controlled multi-centre trial. Radiother Oncol.
100:200–204. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Al-Hilli Z, Choong G, Keeney MG, Visscher
DW, Ingle JN, Goetz MP and Jakub JW: Metaplastic breast cancer has
a poor response to neoadjuvant systemic therapy. Breast Cancer Res
Treat. 176:709–716. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tzanninis IG, Kotteas EA,
Ntanasis-Stathopoulos I, Kontogianni P and Fotopoulos G: Management
and outcomes in metaplastic breast cancer. Clin Breast Cancer.
16:437–443. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
McKinnon E and Xiao P: Metaplastic
carcinoma of the breast. Arch Pathol Lab Med. 139:819–822.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Weigelt B, Kreike B and Reis-Filho JS:
Metaplastic breast carcinomas are basal-like breast cancers: A
genomic profiling analysis. Breast Cancer Res Treat. 117:273–280.
2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhang Y, Toy KA and Kleer CG: Metaplastic
breast carcinomas are enriched in markers of tumor-initiating cells
and epithelial to mesenchymal transition. Mod Pathol. 25:178–184.
2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Prat A, Parker JS, Karginova O, Fan C,
Livasy C, Herschkowitz JI, He X and Perou CM: Phenotypic and
molecular characterization of the claudin-low intrinsic subtype of
breast cancer. Breast Cancer Res. 12(R68)2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Reis-Filho JS, Pinheiro C, Lambros MB,
Milanezi F, Carvalho S, Savage K, Simpson PT, Jones C, Swift S,
Mackay A, et al: EGFR amplification and lack of activating
mutations in metaplastic breast carcinomas. J Pathol. 209:445–453.
2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tseng WH and Martinez SR: Metaplastic
breast cancer: To radiate or not to radiate? Ann Surg Oncol.
18:94–103. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yu JI, Choi DH, Huh SJ, Ahn SJ, Lee JS,
Shin KH, Kwon Y, Kim YB, Suh CO, Kim JH, et al: Unique
characteristics and failure patterns of metaplastic breast cancer
in contrast to invasive ductal carcinoma: A retrospective
multicenter case-control study (KROG 13-7). Clin Breast Cancer.
15:e105–e115. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Jin X, Yu D, Guo C, Gong X, Li N and Zhao
Y: Metaplastic breast carcinoma: A clinical analysis of 26 cases.
Int J Clin Exp Pathol. 11:2112–2117. 2018.PubMed/NCBI
|
|
38
|
Cimino-Mathews A, Verma S,
Figueroa-Magalhaes MC, Jeter SC, Zhang Z, Argani P, Stearns V and
Connolly RM: A clinicopathologic analysis of 45 patients with
metaplastic breast carcinoma. Am J Clin Pathol. 145:365–372.
2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fayaz S, Demian GA, Eissa HE, Amanguno H
and Abuzalouf S: Metaplastic breast carcinoma: Analysis of 31 cases
from a single institute. J Egypt Natl Canc Inst. 29:141–145.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Benson R, Madan R, Julka PK and Rath GK:
Metaplastic carcinoma of breast: A case series of seven patients
from a tertiary care center and review of literature. Gulf J
Oncolog. 1:74–76. 2016.PubMed/NCBI
|
|
41
|
Cha N, Wang S, Lv M, Wang DW, Zhang XJ,
Zheng M and Tian LX: Breast metaplastic squamous cell carcinoma
diagnosed with fine needle and core biopsy: A case study. Am J Case
Rep. 19:203–206. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rakha EA, Coimbra ND, Hodi Z, Juneinah E,
Ellis IO and Lee AH: Immunoprofile of metaplastic carcinomas of the
breast. Histopathology. 70:975–985. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhu H, Li K, Dong DD, Fu J, Liu DD, Wang
L, Xu G and Song LH: Spindle cell metaplastic carcinoma of breast:
A clinicopathological and immunohistochemical analysis. Asia Pac J
Clin Oncol. 13:e72–e78. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Salemis NS: Metaplastic carcinoma of the
breast with mesenchymal differentiation (carcinosarcoma): A unique
presentation of an aggressive malignancy and literature review.
Breast Dis. 37:169–175. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hirose T, Honda J, Bando Y, Sasa M, Hirose
Y, Nagao T and Tangoku A: A case of matrix-producing carcinoma of
the breast. World J Surg Onc. 6(60)2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rakha EA, Tan PH, Varga Z, Tse GM, Shaaban
AM, Climent F, van Deurzen CH, Purnell D, Dodwell D, Chan T and
Ellis IO: Prognostic factors in metaplastic carcinoma of the
breast: A multi-institutional study. Br J Cancer. 112:283–289.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lester TR, Hunt KK, Nayeemuddin KM,
Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis
WG, Valero V and Gilcrease MZ: Metaplastic sarcomatoid carcinoma of
the breast appears more aggressive than other triple
receptor-negative breast cancers. Breast Cancer Res Treat.
131:41–48. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zhang Y, Lv F, Yang Y, Qian X, Lang R, Fan
Y, Liu F, Li Y, Li S, Shen B, et al: Clinicopathological features
and prognosis of metaplastic breast carcinoma: Experience of a
major Chinese cancer center. PLoS One. 10(e0131409)2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yamaguchi R, Horii R, Maeda I, Suga S,
Makita M, Iwase T, Oguchi M, Ito Y and Akiyama F: Clinicopathologic
study of 53 metaplastic breast carcinomas: Their elements and
prognostic implications. Hum Pathol. 41:679–685. 2010.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kaufman MW, Marti JR, Gallager HS and
Hoehn JL: Carcinoma of the breast with pseudosarcomatous
metaplasia. Cancer. 53:1908–1917. 1984.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Smith BD, Bellon JR, Blitzblau R, Freedman
G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, et al:
Radiation therapy for the whole breast: Executive summary of an
American society for radiation oncology (ASTRO) evidence-based
guideline. Pract Radiat Oncol. 8:145–152. 2018.PubMed/NCBI View Article : Google Scholar
|
